Browse All

Current Filters

CLEAR FILTER x

TITLE

Characterization of Neurological Biomarkers in Patients with Early Relapsing Multiple Sclerosis and Comparison to Healthy Controls: Year 1 Interim Analysis of the ENLIGHTEN Study of Ozanimod

Single-cell Cerebrospinal Fluid Transcriptome Profiling Suggests Dysfunctional Boarder Associated Macrophages Underlying Progression Independent of Relapse Activity in Multiple Sclerosis

Trajectories of Serum NfL and GFAP Levels in Newly Diagnosed Multiple Sclerosis Patients After Initiation of Immunomodulatory Treatments